Xiaolong Lin

Dr. Xiaolong Lin


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2017 in International Journal of Molecular Medicine
Verified
Journal Article
Open access
PDF file
XLXiaolong Lin
Xiaolong Lin
HHHui-Jun Hu
Hui-Jun Hu
YLYuan-Bo Liu
Yuan-Bo Liu
XHXue-Mei Hu
Xue-Mei Hu
XFXiao-Juan Fan
Xiao-Juan Fan
CGCai-Hong Gu
Cai-Hong Gu
Allicin is considered anti-atherosclerotic due to its antioxidant and anti-inflammatory effects, which makes it an important drug for the prevention and treatment of atherosclerosis. However, the effects of allicin on foam cells are unclear. Thus, in this study, we examined the effects of allicin on lipid accumulation via peroxisome proliferator-activated receptor γ (PPARγ)/liver X receptor α (LXRα) in THP‑1 macrophage-derived foam cells. THP‑1 cells were exposed to 100 nM phorbol myristate acetate (PMA) for 24 h, and then to oxydized low-density lipoprotein (ox-LDL; 50 mg/ml) to induce foam cell formation. The results of Oil Red O staining and high-performance liquid chromatography (HPLC) revealed showed that pre-treatment of the foam cells with allicin decreased total cholesterol, free cholesterol (FC) and cholesterol ester levels in cells, and also decreased lipid accumulation. Moreover, allicin upregulated ATP binding cassette transporter A1 (ABCA1) expression and promoted cholesterol efflux. However, these effects were significantly abolished by transfection with siRNA targeting ABCA1. Furthermore, PPARγ/LXRα signaling was activated by allicin treatment. The allicin-induced upregulation of ABCA1 expression was also abolished by PPARγ inhibitor (GW9662) and siRNA or LXRα siRNA co-treatment. Overall, our data demonstrate that the allicin-induced upregulation of ABCA1 promotes cholesterol efflux and reduces lipid accumulation via PPARγ/LXRα signaling in THP‑1 macrophage-derived foam cells.

4 December 2014 in Cellular and Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
MLMi-Hua Liu
Mi-Hua Liu
CYCong Yuan
Cong Yuan
JHJun He
Jun He
TTTian-Ping Tan
Tian-Ping Tan
SWShao-Jian Wu
Shao-Jian Wu
XLXiaolong Lin
Xiaolong Lin

10 April 2017 in Biomedical Reports
Verified
Journal Article
Open access
PDF file
XLXiaolong Lin
Xiaolong Lin
YLYuan Bo Liu
Yuan Bo Liu
HHHuijun Hu
Huijun Hu
The hepatokine fibroblast growth factor 21 (FGF21) is a novel polypeptide ligand, which is involved in glucose and lipid metabolism, and contributes significantly to lowering body weight and enhancing insulin sensitivity. A large number of pre‑clinical and clinical results demonstrate that FGF21 is a potential drug target for treating obesity and type 2 diabetes mellitus. In the present review, the tissue specific actions and molecular mechanisms of FGF21 are discussed with a focus on the liver, adipose tissue and nervous system, as well as investigating the outcomes of clinical trials of FGF21, with the aim of interpreting and delineating the complexity physiology of FGF21.

8 June 2016 in Experimental and Therapeutic Medicine
Verified
Journal Article
Open access
PDF file
MLMi-Hua Liu
Mi-Hua Liu
JSJian Shan
Jian Shan
JLJian Li
Jian Li
YZYuan Zhang
Yuan Zhang
XLXiaolong Lin
Xiaolong Lin
Doxorubicin (DOX) is an efficient drug used in cancer therapy; however, it can induce severe cytotoxicity, which limits its clinical application. In the present study, the effects of resveratrol (RES) on sirtuin 1 (SIRT1) activation in mediating DOX-induced cytotoxicity in H9c2 cardiac cells was investigated. H9c2 cells were exposed to 5 µM DOX for 24 h to establish a model of DOX cardiotoxicity. Apoptosis of H9c2 cardiomyocytes was assessed using the MTT assay and Hoechst nuclear staining. The results demonstrated that pretreating H9c2 cells with RES prior to the exposure of DOX resulted in increased cell viability and a decreased quantity of apoptotic cells. Western blot analysis demonstrated that DOX decreased the expression level of SIRT1. These effects were significantly alleviated by co-treatment with RES. In addition, the results demonstrated that DOX administration amplified forkhead box O1 (FoxO1) and P53 expression levels in H9c2 cells. RES was also found to protect against DOX-induced increases of FoxO1 and P53 expression levels in H9c2 cells. Furthermore, the protective effects of RES were arrested by the SIRT1 inhibitor nicotinamide. In conclusion, the results demonstrated that RES protected H9c2 cells against DOX-induced injuries via SIRT1 activation.

1 August 2018 in Journal of Diabetes and its Complications
Verified
Journal Article
Closed access
DGDongmin Guo
Dongmin Guo
LXLele Xiao
Lele Xiao
HHHuijun Hu
Huijun Hu
MLMihua Liu
Mihua Liu
LYLu Yang
Lu Yang
XLXiaolong Lin
Xiaolong Lin

31 January 2017 in Medical Science Monitor
Verified
Journal Article
Open access
PDF file
XLXiaolong Lin
Xiaolong Lin
YLYuanbo Liu
Yuanbo Liu
MLMi-Hua Liu
Mi-Hua Liu
HHHuiJun Hu
HuiJun Hu
YPYongquan Pan
Yongquan Pan
WZWei-Wen Zou
Wei-Wen Zou
BACKGROUND:The abnormal activity of Sirtuin 1 (Sirt1) is closely related to the aging of vascular endothelial cells. As a bioactive molecule, allicin has antioxidant, anti-inflammatory, and lipid-regulating mechanisms. However, few reports about the ...